FDA cleared – MiniTC™
CE Mark pending – Mini-Stem System™
With our devices and technology, we enable healthcare practitioners (HCPs), and hospitals to provide safe, cost-effective non-surgical regenerative medicine therapies at the point-of-care without change in the infrastructure. Both MiniTC™ and Mini-Stem System™ are medical devices that can be used as stand-alone or as a platform for development of clinical therapies and 3D Bioprinting of tissues.
Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 26, 2024 | Jointechlabs Secures CE Mark Approval for Mini-Stem System in Europe, Will Soon Launch Regenerative Medicine Product | Mini-Stem System: Game-Changer in Regenerative Medicine Some of the many uses of microfat (MFAT) and stromal vascular fraction (SVF) Extracting Stromal Vascular Fraction (SVF) The world’s first product to produce injectable microfat and iso... |
| Apr 17, 2018 | Watch IndieBio’s Demo Day today | Today, April 17th at 2:00 PT, TechCrunch is bringing you IndieBio‘s Demo Day. IndieBio is a four-month accelerator focusing on biotech companies. Early-stage companies are given mentorship, 24/7 access to biosafety level 1 and 2 labs on-sit... |
Reviews 0
FAQ about Jointechlabs Inc.
When was Jointechlabs Inc. founded?
Jointechlabs Inc. was founded in 2014.
What has the press written about Jointechlabs Inc.?
Parsers VC has collected 3 articles mentioning Jointechlabs Inc., among them “Jointechlabs Secures CE Mark Approval for Mini-Stem System in Europe, Will Soon Launch Regenerative Medicine Product” (Sep 26, 2024) and “Watch IndieBio’s Demo Day today” (Apr 17, 2018).
Is Jointechlabs Inc. still active?
Yes, Jointechlabs Inc. is active; its latest activity on Parsers VC dates from Apr 3, 2025.